Atlas Trials

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

Clinical trial NCT05575167 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05575167
Sponsor
424 General Military Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Osteoporosis, Postmenopausal
Start date
2023-11-28
Primary completion
2027-07-01
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.